Company / Return on Assets (ROA)
Atara Biotherapeutics, Inc. Return on Assets (ROA) History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
161.5%
FY2025
5-year range
-253.1% / 161.5%
FY2024-FY2025
Trend
+163.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
161.5% in FY2025.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 163.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -73.54 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 161.5% | +163.8% |
| FY2024 | -253.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026